Nemaura Medical (NSDQ:NMRD) said this week that it priced a public offering of the company’s common stock and warrants, hoping to reel in $2.5 million in proceeds.
The offering is slated to close today. Nemaura plans to use the offering’s proceeds to support the launch of its wearable glucose monitor in Europe, as well as the development of its second-generation system and a clinical trial in the U.S.
Get the full story at our sister site, Drug Delivery Business News.
The post Nemaura prices $2.5m offering to support launch of wearable glucose monitor appeared first on MassDevice.
from MassDevice https://ift.tt/2SalLNx
Cap comentari:
Publica un comentari a l'entrada